GB9923156D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
GB9923156D0
GB9923156D0 GBGB9923156.5A GB9923156A GB9923156D0 GB 9923156 D0 GB9923156 D0 GB 9923156D0 GB 9923156 A GB9923156 A GB 9923156A GB 9923156 D0 GB9923156 D0 GB 9923156D0
Authority
GB
United Kingdom
Prior art keywords
novel compounds
novel
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9923156.5A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GlaxoSmithKline Biologicals SA
Original Assignee
SmithKline Beecham Biologicals SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Biologicals SA filed Critical SmithKline Beecham Biologicals SA
Priority to GBGB9923156.5A priority Critical patent/GB9923156D0/en
Publication of GB9923156D0 publication Critical patent/GB9923156D0/en
Priority to CA002386077A priority patent/CA2386077A1/en
Priority to EP00967819A priority patent/EP1216302A2/en
Priority to CN00816501A priority patent/CN1402785A/en
Priority to AU77846/00A priority patent/AU7784600A/en
Priority to PCT/EP2000/009495 priority patent/WO2001023416A2/en
Priority to JP2001526566A priority patent/JP2003511013A/en
Priority to HK02108464.8A priority patent/HK1046931A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • C07K14/212—Moraxellaceae, e.g. Acinetobacter, Moraxella, Oligella, Psychrobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
GBGB9923156.5A 1999-09-30 1999-09-30 Novel compounds Ceased GB9923156D0 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
GBGB9923156.5A GB9923156D0 (en) 1999-09-30 1999-09-30 Novel compounds
CA002386077A CA2386077A1 (en) 1999-09-30 2000-09-26 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
EP00967819A EP1216302A2 (en) 1999-09-30 2000-09-26 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
CN00816501A CN1402785A (en) 1999-09-30 2000-09-26 Novel compounds
AU77846/00A AU7784600A (en) 1999-09-30 2000-09-26 Novel compounds
PCT/EP2000/009495 WO2001023416A2 (en) 1999-09-30 2000-09-26 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
JP2001526566A JP2003511013A (en) 1999-09-30 2000-09-26 BASB132 polypeptides and polynucleotides from Moraxella catarrhalis
HK02108464.8A HK1046931A1 (en) 1999-09-30 2002-11-21 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9923156.5A GB9923156D0 (en) 1999-09-30 1999-09-30 Novel compounds

Publications (1)

Publication Number Publication Date
GB9923156D0 true GB9923156D0 (en) 1999-12-01

Family

ID=10861896

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9923156.5A Ceased GB9923156D0 (en) 1999-09-30 1999-09-30 Novel compounds

Country Status (8)

Country Link
EP (1) EP1216302A2 (en)
JP (1) JP2003511013A (en)
CN (1) CN1402785A (en)
AU (1) AU7784600A (en)
CA (1) CA2386077A1 (en)
GB (1) GB9923156D0 (en)
HK (1) HK1046931A1 (en)
WO (1) WO2001023416A2 (en)

Also Published As

Publication number Publication date
CN1402785A (en) 2003-03-12
CA2386077A1 (en) 2001-04-05
HK1046931A1 (en) 2003-01-30
EP1216302A2 (en) 2002-06-26
WO2001023416A2 (en) 2001-04-05
AU7784600A (en) 2001-04-30
WO2001023416A3 (en) 2001-08-16
JP2003511013A (en) 2003-03-25

Similar Documents

Publication Publication Date Title
EP1140083A4 (en) Novel compounds
GB9902697D0 (en) Novel compounds
GB9928673D0 (en) Novel compounds
EG24063A (en) Novel compounds
GB9901256D0 (en) Novel compounds
GB9902880D0 (en) Novel compounds
GB9902937D0 (en) Novel compounds
GB9902070D0 (en) Novel compounds
GB9917975D0 (en) Novel compounds
GB9901947D0 (en) Novel compounds
GB9903417D0 (en) Novel compounds
GB9900959D0 (en) Novel compounds
GB9901368D0 (en) Novel compounds
GB9901462D0 (en) Novel compounds
GB9901463D0 (en) Novel compounds
GB9923156D0 (en) Novel compounds
GB9901465D0 (en) Novel compounds
GB9901602D0 (en) Novel compounds
GB9901903D0 (en) Novel compounds
GB9901944D0 (en) Novel compounds
GB9901945D0 (en) Novel compounds
GB9901946D0 (en) Novel compounds
GB9900952D0 (en) Novel compounds
GB9907086D0 (en) Novel compounds
GB9902078D0 (en) Novel compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)